Principal Financial Group Inc. purchased a new stake in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 15,343 shares of the company's stock, valued at approximately $361,000. Principal Financial Group Inc. owned approximately 0.17% of Semler Scientific at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of the company. Cerity Partners LLC boosted its position in Semler Scientific by 91.5% during the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company's stock valued at $31,689,000 after purchasing an additional 642,982 shares during the last quarter. Shariaportfolio Inc. acquired a new stake in shares of Semler Scientific in the 3rd quarter valued at approximately $3,618,000. AQR Capital Management LLC boosted its holdings in shares of Semler Scientific by 150.1% in the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company's stock valued at $4,833,000 after buying an additional 84,314 shares during the last quarter. Crawford Fund Management LLC bought a new position in shares of Semler Scientific in the third quarter valued at $883,000. Finally, Dimensional Fund Advisors LP increased its holdings in Semler Scientific by 18.3% during the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company's stock worth $4,341,000 after buying an additional 19,552 shares during the last quarter. 49.37% of the stock is owned by institutional investors and hedge funds.
Semler Scientific Price Performance
SMLR stock traded down $3.70 during trading hours on Tuesday, reaching $55.24. The stock had a trading volume of 366,160 shares, compared to its average volume of 419,413. The stock has a market capitalization of $511.91 million, a PE ratio of 26.95 and a beta of 1.18. The stock has a 50-day simple moving average of $55.94 and a 200 day simple moving average of $38.21. Semler Scientific, Inc. has a fifty-two week low of $20.88 and a fifty-two week high of $81.56.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.35. The business had revenue of $13.51 million during the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.
About Semler Scientific
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
See Also
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.